Natco Pharma Ltd - Share Price
NATCOPHARM
Natco Pharma LtdFinancials
Natco Pharma LtdNews & Updates
Board of Natco Pharma recommends Fourth Interim Dividend
Jun 18,2020 10:09 AM
Of Rs.1 per share
Stock down 4%! Natco Pharma's Q4 earnings hit by decline in Hepatitis C product; Logs PAT of Rs94cr Jun 17,2020
Board of Natco Pharma recommends 4th interim dividend Jun 17,2020
Board of Natco Pharma approves investment in ACCT Inc. USA Jun 17,2020
Natco Pharma fixes record date for 4th interim dividend Jun 17,2020
Natco Pharma slips after Q4 PAT falls 22% Jun 17,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Natco Pharma LtdSummary & Reports
No Company Summary found
Registered Office
Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033
Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in
Registrar Office
12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA
Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com
Reports by natco-pharma-ltd
Latest Release by natco-pharma-ltd
Result Express
Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates
Jul 08, 2020 07:30 AM
The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 48.93% |
| Total Promoter | 48.93% |
| Non Promoter | - |
| Institutions | 32.24% |
| Non-Institutions | 18.83% |
| Total Non-Promoter | 51.07% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Dividend
Annc. Date
17 Jun 2020
Effective. Date
26 Jun 2020
Divi. Type
Interim 4
Divi.(%)
50
Divi. Amt.
1
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More
Purpose
Board Meeting
Exp. Date
17 Jun 2020
Annc. Date
09 Jun 2020
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
Purpose
Dividend
Annc. Date
12 Feb 2020
Effective. Date
24 Feb 2020
Divi. Type
Interim 3
Divi.(%)
175
Divi. Amt.
3.5
The Board of Directors of the Company at their meeting held on 12/2/2020 have declared 3rd Interim D... More
Purpose
Board Meeting
Exp. Date
12 Feb 2020
Annc. Date
03 Feb 2020
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
